methacycline has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Y; Shi, W; Song, N; Yu, K; Zhang, H; Zhou, L | 1 |
| Fendly, BM; Johnson, RM; King, KL; Lipari, MT; Napier, MA; Sarup, JC; Shepard, HM; Ullrich, A | 1 |
| Aubin, F; Castelain, F; Girardin, P; Jeand'heur, A; Moumane, L; Pelletier, F | 1 |
3 other study(ies) available for methacycline and Breast Neoplasms
| Article | Year |
|---|---|
A mechanism underlying the effects of polyunsaturated fatty acids on breast cancer.
Topics: alpha-Linolenic Acid; Arachidonic Acid; Biological Transport, Active; Breast Neoplasms; Calcium; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Diglycerides; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Female; Gene Expression Regulation, Neoplastic; Humans; Protein Subunits; TRPC Cation Channels | 2012 |
Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.
Topics: Antibodies, Monoclonal; Binding Sites, Antibody; Breast Neoplasms; Diglycerides; Female; Humans; Oncogene Proteins, Viral; Ovarian Neoplasms; Phosphatidylinositols; Protein-Tyrosine Kinases; Receptor, ErbB-2; Receptors, Cell Surface; Signal Transduction; Tumor Cells, Cultured | 1991 |
A case of immediate hypersensitivity reaction after an oral administration of patent blue dye.
Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Breast Neoplasms; Coloring Agents; Excipients; Female; Humans; Hypersensitivity, Immediate; Intradermal Tests; Methacycline; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests; Urticaria | 2020 |